1. China Stocks

  2. •

    Commercial services

  3. •

    Personnel services
Jinhai Medical Technology Limited

Jinhai Medical Technology Limited

HHKEX:2225
3.80
HKD
-0.15
(-3.80%)
6.61BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.01
0.01
0.01
0.01
0.01
0.01
- -
- -
- -
0.01
0.01
0.01
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
0.01
0.01
- -
- -
- -
- -
0.01
0.01
0.01
0.01
Tangible Book Value per Share
- -
- -
- -
0.01
0.01
- -
- -
- -
- -
0.01
0.01
0.01
0.01
Basic Weighted Avg Shares
4,920
4,920
4,920
4,284
4,920
4,920
4,920
4,920
4,920
4,971
5,170
5,216
5,228
Sales/Revenue/Turnover
45
46
45
44
47
52
22
22
22
46
50
46
- -
Operating Margin (%)
17.41
16.68
17.79
5.52
-6.72
-0.97
4.3
1.69
1.2
-9.67
-39.84
-38.66
- -
Depreciation Expense
2
2
1
1
1
6
6
5
4
4
5
5
- -
Net Income, GAAP
4
6
7
2
-4
-1
1
- -
- -
-3
-18
-17
- -
Effective Tax Rate (%)
13.87
14.69
12.69
27.62
- -
901.92
11.41
- -
85.2
- -
- -
- -
- -
Profit Margin (%)
9.22
13.72
14.69
5.13
-7.46
-1.32
5.62
-1.12
2.1
-6.88
-35.76
-36.91
- -
Working Capital
3
10
7
24
20
17
18
21
19
21
7
29
29
LT Debt
1
- -
- -
- -
- -
5
1
- -
2
3
3
2
2
Total Equity
7
13
10
29
25
24
24
24
25
37
33
52
52
Return on Invested Capital (%)
- -
49.51
49.78
6.74
- -
9.76
3.73
- -
0.33
- -
- -
- -
- -
Return on Capital (%)
- -
52.81
55.57
11.34
- -
-14.05
4.8
- -
3.03
- -
- -
- -
- -
Return on Common Equity (%)
- -
63.05
57.15
11.58
-13.05
-2.79
5.2
-1.01
1.92
-10.16
-51.86
-41.11
- -

Capital Structure

SGD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
12
13
13
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5,170
5,170
5,290
Market Capitalization
1,726
1,189
1,092

Working Capital

SGD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
30
24
64
Cash, Cash Equivalents & STI
15
7
37
Accounts Receivable, Net
5
4
15
Inventories
3
3
3
Total Current Liabilities
23
20
35
Payables & Accruals
- -
- -
- -
ST Debt
12
13
13
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.2%
19.86%
58.52%
Free Cash Flow
-74.07%
-36.9%
32.76%
Net Income, GAAP
-139.48%
-142.74%
-4.93%
Sales/Revenue/Turnover
6.21%
21.25%
-7.89%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
46
2024
- -
- -
50
2025
- -
- -
46

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Zhen Fei Wang
Full Time Employees
485
Sector
Commercial services
Industry
Personnel services
Address
Chinachem Century Tower Shanghai China
IPO Date
Oct 17, 2017
Website
jin-hai.com.hk
Similar Companies
Baiya International Group Inc. (NASDAQ:BIYA)
Quess Corp. Ltd. (NSE:QUESS)
Lucas GC Limited (NASDAQ:LGCL)
Upwork Inc. (NASDAQ:UPWK)
AMN Healthcare Services Inc (NYSE:AMN)
ManpowerGroup (NYSE:MAN)
Business
Jinhai Medical Technology Limited Jinhai Medical Technology Limited (2225.HK 2225.HK), an investment holding company founded in 2006 and headquartered in Shanghai, People's Republic of China, principally engages in providing minimally invasive surgery solutions, medical products, and related services in Mainland China and Singapore; manpower outsourcing and ancillary services to building and construction contractors; dormitory services; information technology services; construction ancillary services including warehousing, cleaning, and building maintenance; engineering design and consultancy services; and sales of graphene material products. The company operates as a subsidiary of Full Fortune International Co., Ltd. and maintains a presence in the staffing and employment services industry within the industrials sector, with approximately 488 employees serving primarily the construction sector in Singapore and the medical device market in China. In December 2023, the company, formerly known as Jinhai International Group Holdings Limited, changed its name to Jinhai Medical Technology Limited to reflect its strategic pivot toward medical technology; it completed the acquisition of Neuhaus Engineering on January 31, 2024; announced a strategic cooperation framework agreement with Medtronic in November 2024; entered a five-year cooperation framework agreement with Ningbo David Medical Device's subsidiary on July 2, 2025, for joint development and global marketing of endoscopic products including real-time navigation spinal endoscope techniques; established a general sales agreement with Sinopharm; raised HKD 161 million through a share placement for potential mergers, acquisitions, and investments; and reported growth in its minimally invasive surgery solutions business driven by new product launches and expanded distribution channels in China.